GSK plc ADR sell Barclays PLC
Start price
20.02.26
/
50%
€50.50
Target price
20.02.27
-
Performance (%)
-15.25%
Price
09.06.26
€44.40
Summary
This prediction is currently active. The price of GSK plc ADR has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.25%. This prediction currently runs until 20.02.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| GSK plc ADR | 2.304% | 2.304% |
| iShares Core DAX® | -2,49 % | 0,32 % |
| iShares Nasdaq 100 | -4,40 % | 1,59 % |
| iShares Nikkei 225® | -4,29 % | 0,97 % |
| iShares S&P 500 | -2,20 % | 2,00 % |
Comments by Barclays_PLC for this prediction
In the thread GSK plc ADR diskutieren
GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for GSK provided by MarketBeat